询 单
请 填 写 相 关 信 息
产品信息
产品名称
别名
CAS号
结构式 上传
联系方式
公司
联系人
电话
邮箱
内容
提交
中文版 English
请输入产品名称、CAS式、分子式
1-Fluoro-4-(2-nitrovinyl)benzene | CAS:706-08-1 (5153-69-5)
1-Fluoro-4-(2-nitrovinyl)benzene
  • 名称:1-(4-氟苯基)-2-硝基乙烯; 4-氟-beta-硝基苯乙烯 | 1-Fluoro-4-(2-nitrovinyl)benzene
  • CAS号:706-08-1 (5153-69-5)
  • 别名:1-(4-Fluorophenyl)-2-nitroethylene; 4-Fluoro-beta-nitrostyrene; (E)-1-Fluoro-4-(2-nitrovinyl)benzene
  • 分子式:C8H6FNO2
  • 分子量:167.14
  • EINESC号:

产品描述

物理化学性质

熔点 100-102 ºC

安全数据

没有数据没有数据

SDS

来源 SDS样本
Alfa-Aesar 浏览或下载
Sigma-Aldrich 浏览或下载
Apollo 浏览或下载
产品合成路线
更多

名称 CAS号
更多
文章
同行评议文献
Evaluation of arterial stiffness in morning hypertension under high-dose valsartan compared to valsartan plus low-dose diuretic.Takeshi Takami Hypertension research : official journal of the Japanese Society of Hypertension, 32(12), 1086-1090 (2009-09-26) TARP auxiliary subunits switch AMPA receptor antagonists into partial agonists.Karen Menuz et al.Science (New York, N.Y.), 318(5851), 815-817 (2007-11-03) Angiotensin-II receptor antagonist combined with calcium channel blocker or diuretic for essential hypertension.Toshihiko Ishimitsu et al.Hypertension research : official journal of the Japanese Society of Hypertension, 32(11), 962-968 (2009-08-22) [Simultaneous analysis of four diuretic drugs by HPLC and its application to health food supplements advertising weight reduction].Tomomi Goto et al.Shokuhin eiseigaku zasshi. Journal of the Food Hygienic Society of Japan, 43(2), 95-98 (2002-07-03) Combination therapy of calcium channel blocker and angiotensin II receptor blocker reduces augmentation index in hypertensive patients.Masayuki Doi et al.The American journal of the medical sciences, 339(5), 433-439 (2010-03-18) Effects of an ARB on endothelial progenitor cell function and cardiovascular oxidation in hypertension.Yi Yu et al.American journal of hypertension, 21(1), 72-77 (2007-12-20) Successful treatment of partial nephrogenic diabetes insipidus with thiazide and desmopressin.Haruo Mizuno et al.Hormone research, 59(6), 297-300 (2003-06-05) Upregulation of ligand, receptor system, and amidating activity of adrenomedullin in left ventricular hypertrophy of severely hypertensive rats: effects of angiotensin-converting enzyme inhibitors and diuretic.Xin Wang et al.Journal of hypertension, 21(6), 1171-1181 (2003-06-05) Effect of pharmaceutical excipients on the stability of trichlormethiazide tablets under humid conditions.Reiko Teraoka et al.Chemical & pharmaceutical bulletin, 57(12), 1343-1347 (2009-12-03) CUL3 gene analysis enables early intervention for pediatric pseudohypoaldosteronism type II in infancy.Madori Osawa et al.Pediatric nephrology (Berlin, Germany), 28(9), 1881-1884 (2013-05-22) Influence of the angiotensin II receptor antagonist losartan on diuretic-induced metabolic effects in elderly hypertensive patients: comparison with a calcium channel blocker.K Ohnishi et al.International journal of clinical pharmacology and therapeutics, 39(10), 417-422 (2001-10-30) Interactions of diuretics with a neutral temperature-responsive polymer: study by capillary electroporesis and dynamic light scattering.S K Wiedme et al.Journal of capillary electrophoresis and microchip technology, 6(5-6), 163-168 (2001-10-30) Antioxidative effects of thiazide diuretics in refractory hypertensive patients. A randomized crossover trial of chlortalidone and trichlormethiazide.Koichi Sato et al.Arzneimittel-Forschung, 60(10), 612-616 (2010-12-04) Clinical characteristics of eight patients with congenital nephrogenic diabetes insipidus.Haruo Mizuno et al.Endocrine, 24(1), 55-59 (2004-07-14) Change in the circadian rhythm of blood pressure in pseudo-hypoaldosteronism type 2 in response to thiazide diuretics.T Uzu et al.Clinical nephrology, 61(5), 367-368 (2004-06-09) Successful conversion from thiazide to tolvaptan in a patient with stage d heart failure and chronic kidney disease before heart transplantation.Teruhiko Imamura et al.International heart journal, 54(1), 48-50 (2013-02-23) Adverse effect profile of trichlormethiazide: a retrospective observational study.Yasuo Takahashi et al.Cardiovascular diabetology, 10, 45-45 (2011-05-25) A case of exercise-induced acute renal failure in a patient with idiopathic renal hypouricemia developed during antihypertensive therapy with losartan and trichlormethiazide.Osamu Ito et al.Hypertension research : official journal of the Japanese Society of Hypertension, 26(6), 509-513 (2003-07-17) Carbonic anhydrase inhibitors. Comparison of chlorthalidone, indapamide, trichloromethiazide, and furosemide X-ray crystal structures in adducts with isozyme II, when several water molecules make the difference.Claudia Temperini et al.Bioorganic & medicinal chemistry, 17(3), 1214-1221 (2009-01-03) Thiazide diuretics enhance nocturnal blood pressure fall and reduce proteinuria in immunoglobulin A nephropathy treated with angiotensin II modulators.Takashi Uzu et al.Journal of hypertension, 23(4), 861-865 (2005-03-19) A novel compound heterozygous mutation of Gitelman's syndrome in Japan, as diagnosed by an extraordinary response of the fractional excretion rate of chloride in the trichlormethiazide loading test.Kohei Ueda et al.Internal medicine (Tokyo, Japan), 51(12), 1549-1553 (2012-06-26) Genetic knockout and pharmacologic inhibition of NCX2 cause natriuresis and hypercalciuria.Yusuke Gotoh et al.Biochemical and biophysical research communications, 456(2), 670-675 (2014-12-17) Tolerability and safety of a calcium channel blocker in comparison with a diuretic in the treatment of elderly patients with hypertension: secondary analysis of the NICS-EH.I Kuwajima et al.Hypertension research : official journal of the Japanese Society of Hypertension, 24(5), 475-480 (2001-10-26) Comparison of effects of low dose of spironolactone and a thiazide diuretic in patients with hypertension treated with an angiotensin-converting enzyme inhibitor or an angiotensin type 1 receptor blocker.Miyashita Yutaka et al.Clinical and experimental hypertension (New York, N.Y. : 1993), 31(8), 648-656 (2009-12-17) Salt-losing nephrogenic diabetes insipidus caused by fetal exposure to angiotensin receptor blocker.Kenichiro Miura et al.Pediatric nephrology (Berlin, Germany), 24(6), 1235-1238 (2009-01-21) Targeting AMPA receptor gating processes with allosteric modulators and mutations.Nicholas A Mitchell et al.Biophysical journal, 92(7), 2392-2402 (2007-01-09) Angiotensin II type 1 receptor blockers reduce urinary oxidative stress markers in hypertensive diabetic nephropathy.Susumu Ogawa et al.Hypertension (Dallas, Tex. : 1979), 47(4), 699-705 (2006-03-01)
备注

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

名称 CAS号

相关产品

相关资讯

热门标签
询 单
请 填 写 相 关 信 息
产品信息
产品名称
别名
CAS号
结构式 上传
联系方式
公司
联系人
电话
邮箱
内容
提交